Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Comparison of NVP-1203 vs Eperisone SR and Aceclofenac Co-administration
NCT02289274Phase 1Withdrawn
- Sponsor
- NVP Healthcare Co., Ltd.
- Start
- Nov 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of eperisone + aceclofenac in low back pain (LBP) (2 arms), sponsored by NVP Healthcare Co., Ltd. Primary endpoint: Area Under Curve last. Planned start Nov 2019; status: withdrawn.
02
Drugs
eperisone + aceclofenac
03
Conditions
low back pain (LBP)
Beyond the preview
Go deeper on NCT02289274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02289274.